Glaxo Smith Kline (BIOC)
Last update: 22 July 01:29 PM market time.
0.27
0.61%
Open
44.13
Previous Close
44.13
High
45.40
Low
43.90
Stock Statistics
Volume
202,911
Turnover
9,073,262.00
All data are 15 minutes late during market session
- Stock
- Company Profile
- News
- Announcements
- Fair Values
- Corporate Actions
- Earning Announcements
- News Reports
- Insider Trades
- Volume Statistics
- Financial Ratios
- IPOs
- Financial Statements
- Support and resistance
- More
General Information
Company Name
Glaxo Smith Kline (BIOC)
Company Purpose
Glaxo SmithKline is a public company, listed on Egyptian Exchange (EGX) since October 1985. It operates within the Pharmaceuticals, Biotechnology and Life Sciences sector focusing on Pharmaceuticals. Glaxo SmithKline is based in Cairo, Egypt and was established in January 1981.
Company Establish Date
14 January 1981
Financial Year Start
First Quarter
Auditor
- Baker Tilly - Wahid Abdel Ghaffar and Co
- Wafiq Alfred Hanna
Ownership
- Glaxo Group Ltd (91.20%)
- Qatar National Bank (5.89%)
Management
Ahmed Abdel Hamid Fahmy Khattab
Chairman
Represents
Glaxo Group Ltd
Hassan Mahmoud Hassan Mahmoud Fahmy
Managing director
Represents
Glaxo Group Ltd
Munir Ghabbour Hanna
Board Members
Shirin Al Ansary
Board Members
Represents
Qatar National Bank
Omnia Saad Abd El Rahman Kelig
Board Members
Laila Daniel Shaker Boles
Board Members
Represents
Glaxo Group Ltd
Mohammad Ali Abdul Azim
Board Members
Represents
Glaxo Group Ltd
Vikas Jan
Board Members
Represents
Glaxo Group Ltd
Omar Sameh Shoukry
Board Members
Represents
Glaxo Group Ltd
Subsidiaries
- Amoun Pharmaceutical Industries (99.64%)
- Modern Pharma International (20.00%)
Contacts
Address
Boomerang Buliding, New Cairo, Cairo, P.O. Box 41.
Phone
+20 2 26185000
Fax
+20 2 26185001
Email
mohsen.x.bebawy@gsk.com
Contact Person
Omar Sameh Shoukry
